Definitive Healthcare Corp. (NASDAQ:DH) saw a downside of -9.71% to $9.16 after subtracting -$0.99on Wednesday. The 5-day average trading volume is 652,584 shares of the company’s common stock. It has gained $10.24 in the past week and touched a new high 2 times within the past 5 days. An average of 516,821 shares of the company has been traded in the last 20 days, and the 50-day average volume stands at 646,378.
DH’s 1-month performance is -20.10% or -$2.36 on its low of $9.09 reached on 08/23/23. The company’s shares have touched a 52-week low of $8.71 and high of $22.15, with the stock’s rally to the 52-week high happening on 02/02/23. YTD, DH has lost -16.61% or -$1.82 and has reached a new high 6 times. However, the current price is down -58.62% from the 52-week high price.
Insider Transactions
DH stock investors last saw insider trading activity on May 12.SEA VII Management, LLC (Director) most recently sold 6,240 shares at $9.11 per share on May 12. This transaction cost the insider $56,846.
Valuation Metrics
DH stock has a beta of 0.74. Moving on to other valuation ratios, the trailing price-to-sales (P/S) ratio is 6.12 while the price-to-book (PB) in the most recent quarter is 1.02, with the price to cash flow ratio at 59.04.
Definitive Healthcare Corp.’s quick ratio for the period ended June 29 was 2.80, with the current ratio over the same period at 2.80. As well, the company’s long term debt to equity for the quarter ending June 29 was 0.25, while the total debt to equity was 0.26. In terms of profitability, the gross margin trailing 12 months is 82.10%. The trailing 12-month EBITDA margin is 10.57% while for the period ending June 29, Definitive Healthcare Corp.’s operating margin was -18.20%. The firm’s gross profit as reported stood at $180.03 million against revenue of $222.65 million.
Earnings Surprise
For the quarterly period ending June 29 this year, Net income and sales went up compared to those figures reported in the previous quarter. Net income grew 39.91% to -$8.57 million, while revenue of -$12.06 million was -40.72% off the previous quarter. Analysts expected DH to announce $0.05 per share in earnings in its latest quarter, but it posted $0.08, representing a 60.00% surprise. EBITDA for the quarter stood at more than $4.05 million. DH stock balance sheet for the quarter ending June 29 shows that total liabilities totaled 649.4 million, with total debt at $271.91 million. Shareholders hold equity totaling $113.3 million.
Let’s look briefly at Definitive Healthcare Corp. (DH) price momentum from a technical analysis perspective. The 9-day relative strength index as at close on 22 August was 21.77% to suggest the stock is trending oversold, with historical volatility in this time period at 51.30%.
The stock’s 5-day moving average is $9.84, reflecting a -8.30% or -$0.83 change from its current price. DH is currently trading -24.21% above its 20-day SMA, -5.66% above its 100-day SMA. However, the stock’s current price level is away from the SMA50 by -13.73% and SMA200 by-33.69%.
Stochastic %K and %D was 19.00% and 20.70% and the average true range (ATR) pointed at 0.56. The RSI (14) points at 28.80%, while the 14-day stochastic is at 3.19% with the period’s ATR at 0.56. The stock’s 9-day MACD Oscillator is pointing at -0.27 and -0.64 on the 14-day charts.
Analyst Ratings
In the most recent analyst report for Definitive Healthcare Corp. (NASDAQ: DH), Robert W. Baird downgraded it to a Neutral rating. They previously had an Outperform rating on the stock.
What is DH’s price target for the next 12 months?
Analysts have a consensus price target ranging from a low of $10.00 and a high of $15.50, with their median price target at $12.00. Looking at these predictions, the average price target given by analysts is for Definitive Healthcare Corp. (DH) stock is $12.54.
